AstraZeneca has opened its first U.S.-operated cell therapy manufacturing facility in Rockville, Maryland, as part of its ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

AstraZeneca (AZN) reported mixed first quarter earnings results, missing on revenue estimates but beating on earnings per ...

The facility to manufacture cell therapies for cancer research is part of the company's push to invest $3.5B in its U.S.

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the ...

Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro ...

The drug, a small molecule protein inhibitor, brought in $132 million in the first quarter, missing consensus estimates by 17 ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to attack cancer.

(Alliance News) - AstraZeneca PLC on Wednesday said it has received positive high-level results from its latest trial evaluating Enhertu in patients with high-risk, locally advanced HER2-positive ...